Brett Jensen touts a new class of cardiac drugs and the company making it in Biotech Jems. Any ideas?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.